Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1982 1
1984 2
1986 1
1987 1
1988 1
1990 1
1991 2
1992 1
1993 3
1996 1
1997 1
1998 2
1999 1
2001 1
2002 4
2003 4
2004 3
2005 2
2006 1
2007 1
2008 1
2009 2
2010 2
2011 4
2012 3
2013 5
2014 2
2015 4
2016 3
2017 4
2018 3
2019 6
2020 2
2021 3
2022 7
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Metastatic Urethral Urothelial Carcinoma"
Page 1
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.
Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Chan K, Chang S, Friedlander T, Greenberg RE, Guru KA, Herr HW, Hoffman-Censits J, Kishan A, Kundu S, Lele SM, Mamtani R, Margulis V, Mian OY, Michalski J, Montgomery JS, Nandagopal L, Pagliaro LC, Parikh M, Patterson A, Plimack ER, Pohar KS, Preston MA, Richards K, Sexton WJ, Siefker-Radtke AO, Tollefson M, Tward J, Wright JL, Dwyer MA, Cassara CJ, Gurski LA. Flaig TW, et al. J Natl Compr Canc Netw. 2022 Aug;20(8):866-878. doi: 10.6004/jnccn.2022.0041. J Natl Compr Canc Netw. 2022. PMID: 35948037
The NCCN Guidelines for Bladder Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with bladder cancer and other urinary tract cancers (upper tract tumors, urothelial carcinoma of the prostate, primary carcinoma …
The NCCN Guidelines for Bladder Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with blad …
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines.
Alfred Witjes J, Max Bruins H, Carrión A, Cathomas R, Compérat E, Efstathiou JA, Fietkau R, Gakis G, Lorch A, Martini A, Mertens LS, Meijer RP, Milowsky MI, Neuzillet Y, Panebianco V, Redlef J, Rink M, Rouanne M, Thalmann GN, Sæbjørnsen S, Veskimäe E, van der Heijden AG. Alfred Witjes J, et al. Eur Urol. 2024 Jan;85(1):17-31. doi: 10.1016/j.eururo.2023.08.016. Epub 2023 Oct 17. Eur Urol. 2024. PMID: 37858453 Review.
Pathologists should describe tumour and lymph nodes in detail, including the presence of histological subtypes. The importance of the presence or absence of urothelial carcinoma (UC) in the prostatic urethra is emphasised. Magnetic resonance imaging (MRI) of …
Pathologists should describe tumour and lymph nodes in detail, including the presence of histological subtypes. The importance of the presen …
Urethral recurrence after cystectomy: current preventative measures, diagnosis and management.
Chan Y, Fisher P, Tilki D, Evans CP. Chan Y, et al. BJU Int. 2016 Apr;117(4):563-9. doi: 10.1111/bju.13370. Epub 2015 Dec 12. BJU Int. 2016. PMID: 26556525 Review.
To summarise the current literature on the diagnosis and management of urethral recurrence (UR) after radical cystectomy (RC), as UR after RC is rare but associated with high mortality. With the recently increased use of orthotopic bladder substitution and the questionable …
To summarise the current literature on the diagnosis and management of urethral recurrence (UR) after radical cystectomy (RC), as UR …
Radiotherapy in Metastatic Urothelial Carcinoma: Rationale and Clinical Applications.
Vassiliou V, Katsila T, Sodergren SC, Kardamakis D. Vassiliou V, et al. Anticancer Res. 2022 Aug;42(8):3767-3778. doi: 10.21873/anticanres.15867. Anticancer Res. 2022. PMID: 35896266 Review.
Urothelial carcinoma is the most common type of bladder cancer including upper urinary tract urothelial cell carcinoma (renal pelvis and ureters) and urethral carcinoma. It exhibits high mortality and morbidity rates and is usually …
Urothelial carcinoma is the most common type of bladder cancer including upper urinary tract urothelial cell …
Diagnosis and management of urothelial carcinoma of the bladder.
Tanaka MF, Sonpavde G. Tanaka MF, et al. Postgrad Med. 2011 May;123(3):43-55. doi: 10.3810/pgm.2011.05.2283. Postgrad Med. 2011. PMID: 21566415 Review.
More than 90% of bladder carcinomas are classified as urothelial carcinoma (UC), which arise from the urothelium. This epithelium, also known as transitional cell epithelium, lines the urinary tract, which extends from the renal pelvis through the uret …
More than 90% of bladder carcinomas are classified as urothelial carcinoma (UC), which arise from the urothelium. This epithel …
Follow-up Management of Cystectomy Patients.
Reddy M, Kader K. Reddy M, et al. Urol Clin North Am. 2018 May;45(2):241-247. doi: 10.1016/j.ucl.2018.01.001. Urol Clin North Am. 2018. PMID: 29650139 Review.
Distant metastases are the most common; local, upper tract, and urethral recurrence can also occur. Surveillance after cystectomy is critical to diagnosing recurrence early. ...
Distant metastases are the most common; local, upper tract, and urethral recurrence can also occur. Surveillance after cystectomy is …
Mucinous and secondary tumors of the prostate.
Osunkoya AO. Osunkoya AO. Mod Pathol. 2018 Jan;31(S1):S80-S95. doi: 10.1038/modpathol.2017.132. Mod Pathol. 2018. PMID: 29297488 Free article. Review.
This tumor is aggressive and has a relatively poor prognosis. The most common secondary tumors that arise from adjacent organs and spread (direct extension or metastasis) to the prostate gland, include urothelial carcinoma of the bladder and colorectal adenoc …
This tumor is aggressive and has a relatively poor prognosis. The most common secondary tumors that arise from adjacent organs and sp …
Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.
Gakis G, Black PC, Bochner BH, Boorjian SA, Stenzl A, Thalmann GN, Kassouf W. Gakis G, et al. Eur Urol. 2017 Apr;71(4):545-557. doi: 10.1016/j.eururo.2016.09.035. Epub 2016 Oct 6. Eur Urol. 2017. PMID: 27720534 Free PMC article. Review.
CONTEXT: Urothelial carcinoma is considered a pan-urothelial disease. As such, the remnant urothelium in the upper urinary tract and urethra following radical cystectomy (RC) remains at risk for secondary urothelial tumors (SUTs). ...Risk …
CONTEXT: Urothelial carcinoma is considered a pan-urothelial disease. As such, the remnant urothelium in the upper urin …
Female urethral carcinoma: a contemporary review of the clinicopathologic features, with emphasis on the histoanatomic landmarks and potential staging issues.
Lagarde-Lenon MS, Aron M. Lagarde-Lenon MS, et al. Hum Pathol. 2022 Nov;129:71-80. doi: 10.1016/j.humpath.2022.08.003. Epub 2022 Aug 28. Hum Pathol. 2022. PMID: 36037997 Review.
Primary female urethral carcinoma (PUC-F) accounts for less than 1% of all genitourinary malignancies and comprises a histologically diverse group of tumors that are usually associated with poor prognosis. The carcinomas documented at this site include adenocarcinom …
Primary female urethral carcinoma (PUC-F) accounts for less than 1% of all genitourinary malignancies and comprises a histolog …
Urothelial carcinoma metastases impacting the CNS: A 20-year retrospective series.
Guzman SJ, Kleinschmidt-DeMasters BK. Guzman SJ, et al. Ann Diagn Pathol. 2023 Jun;64:152109. doi: 10.1016/j.anndiagpath.2023.152109. Epub 2023 Jan 27. Ann Diagn Pathol. 2023. PMID: 36822051
However, one of the least frequent types of systemic malignancies to metastasize to brain or spine is urothelial carcinoma. Thus, few large studies from a single institution exist. ...Strikingly, 5 of 15 patients had had their CNS-impacting metastasis as their first …
However, one of the least frequent types of systemic malignancies to metastasize to brain or spine is urothelial carcinoma. Th …
84 results